LRP6 and autoimmune polyendocrinopathy: This observation fully agrees with the identification of oxidized phospholipids as ligands for LRP6, revealing that LRP6 serves as a specific receptor for oxidized phospholipids, which are products of lipid oxidation involved in pathological conditions such as atherosclerosis, inflammation, and APS [44].